1. Home
  2. FATE vs KLTR Comparison

FATE vs KLTR Comparison

Compare FATE & KLTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • KLTR
  • Stock Information
  • Founded
  • FATE 2007
  • KLTR 2006
  • Country
  • FATE United States
  • KLTR United States
  • Employees
  • FATE N/A
  • KLTR N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • KLTR EDP Services
  • Sector
  • FATE Health Care
  • KLTR Technology
  • Exchange
  • FATE Nasdaq
  • KLTR Nasdaq
  • Market Cap
  • FATE 406.5M
  • KLTR 389.2M
  • IPO Year
  • FATE 2013
  • KLTR 2021
  • Fundamental
  • Price
  • FATE $1.27
  • KLTR $2.28
  • Analyst Decision
  • FATE Hold
  • KLTR Buy
  • Analyst Count
  • FATE 10
  • KLTR 2
  • Target Price
  • FATE $6.75
  • KLTR $2.25
  • AVG Volume (30 Days)
  • FATE 3.2M
  • KLTR 729.0K
  • Earning Date
  • FATE 02-24-2025
  • KLTR 02-20-2025
  • Dividend Yield
  • FATE N/A
  • KLTR N/A
  • EPS Growth
  • FATE N/A
  • KLTR N/A
  • EPS
  • FATE N/A
  • KLTR N/A
  • Revenue
  • FATE $13,447,000.00
  • KLTR $177,586,000.00
  • Revenue This Year
  • FATE N/A
  • KLTR $3.34
  • Revenue Next Year
  • FATE N/A
  • KLTR $1.88
  • P/E Ratio
  • FATE N/A
  • KLTR N/A
  • Revenue Growth
  • FATE N/A
  • KLTR 1.62
  • 52 Week Low
  • FATE $1.04
  • KLTR $0.76
  • 52 Week High
  • FATE $8.83
  • KLTR $2.82
  • Technical
  • Relative Strength Index (RSI)
  • FATE 31.94
  • KLTR 51.45
  • Support Level
  • FATE $1.22
  • KLTR $1.93
  • Resistance Level
  • FATE $1.36
  • KLTR $2.82
  • Average True Range (ATR)
  • FATE 0.15
  • KLTR 0.20
  • MACD
  • FATE -0.02
  • KLTR -0.02
  • Stochastic Oscillator
  • FATE 24.21
  • KLTR 39.33

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About KLTR Kaltura Inc.

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.

Share on Social Networks: